Trustmark National Bank Trust Department’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-5,729
Closed -$233K – 235
2019
Q3
$233K Sell
5,729
-91
-2% -$3.85K 0.02% 219
2019
Q2
$250K Buy
5,820
+398
+7% +$15.3K 0.02% 213
2019
Q1
$208K Buy
5,422
+3,869
+249% +$148K 0.02% 226
2018
Q4
$55K Hold
1,553
– – 0.01% 321
2018
Q3
$60K Buy
+1,553
New +$54.2K 0.01% 340
2016
Q2
– Sell
-10,327
Closed -$194K – 298
2016
Q1
$194K Buy
10,327
+163
+2% +$2.86K 0.03% 307
2015
Q4
$188K Buy
+10,164
New +$182K 0.03% 308

Other funds holding BSX

Trustmark National Bank Trust Department's BSX Position: Q4 2019 in Review

Trustmark National Bank Trust Department sold out of Boston Scientific (BSX) in Q4 2019, closing a stake of 5,729 shares — an estimated $233K sold.

Trustmark National Bank Trust Department first reported a position in BSX in Q4 2015 and held it in 7 quarters. The position peaked at $250K in Q2 2019. 854 funds tracked by Wall St. Rank hold BSX as of Q4 2019.

  • Trustmark National Bank Trust Department reported no remaining Boston Scientific position as of Q4 2019 after selling out during the quarter.
  • Trustmark National Bank Trust Department sold 5,729 Boston Scientific shares in Q4 2019, an estimated $233K.
  • Trustmark National Bank Trust Department first reported a position in Boston Scientific in Q4 2015 and held it in 7 quarters.
  • Trustmark National Bank Trust Department's Boston Scientific position peaked at $250K in Q2 2019.
  • 854 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2019.

Based on Trustmark National Bank Trust Department's 13F filing for Q4 2019, filed 14 Feb 2020.